INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09969 INNOCARE

Market Closed 04-02 16:08:21

15.520

+0.660

+4.44%

High15.610	Low14.720	Vol21.56M
Open15.300	D1 Closing14.860	Amplitude5.99%
Mkt Cap27.35B	Tradable Cap23.19B	Total Shares1.76B
T/O330.47M	T/O Rate1.44%	Tradable Shares1.49B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"INNOCARE","latestPrice":15.52,"timestamp":1775117301010,"preClose":14.86,"halted":0,"volume":21556000,"delay":0,"changeRate":0.044414535666218044,"floatShares":1494000000,"shares":1762000000,"eps":0.42680253679029373,"marketStatus":"Market Closed","change":0.66,"latestTime":"04-02 16:08:21","open":15.3,"high":15.61,"low":14.72,"amount":330465616,"amplitude":0.059892,"askPrice":15.53,"askSize":10000,"bidPrice":15.52,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.42680253679029373,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":14.86,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.5360015286424027,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"Innocare Pharma Limited","latestPrice":29.38,"timestamp":1775199600000,"preClose":29.95,"halted":0,"volume":22334500,"delay":0,"premium":"-53.56"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"1164546936","title":"Goldman Sachs Slightly Raises Innocare Target to HK$19.93 on Strong Q4 Sales of Orelabrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1164546936","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164546936?lang=en_us&edition=fundamental","pubTime":"2026-03-30 15:40","pubTimestamp":1774856423,"startTime":"0","endTime":"0","summary":"Goldman Sachs has issued a research report noting that INNOCARE (09969) reported sales of Orelabrutinib reaching RMB 390 million in the fourth quarter of last year, a 27% year-on-year increase....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969","BK0239","BK1161","BK1574","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623635363","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2623635363","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623635363?lang=en_us&edition=fundamental","pubTime":"2026-03-30 02:06","pubTimestamp":1774807596,"startTime":"0","endTime":"0","summary":"Recent share performance and business snapshot\nInnoCare Pharma (SEHK:9969) has drawn investor attention after a 5.7% one day gain, adding to a one month return of 12.8% and a past 3 months return recorded as 0%.\nThe Hong Kong listed biopharmaceutical group focuses on cancer and autoimmune disease treatments in China, with revenue of CN¥2,374.906 million and net income of CN¥642.467 million reported in its latest figures.\nSee our latest analysis for InnoCare Pharma.\nAt the current share price...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","09969","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622049558","title":"The InnoCare Pharma Limited (HKG:9969) Yearly Results Are Out And Analysts Have Published New Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2622049558","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622049558?lang=en_us&edition=fundamental","pubTime":"2026-03-28 07:53","pubTimestamp":1774655610,"startTime":"0","endTime":"0","summary":"Investors in InnoCare Pharma Limited ( HKG:9969 ) had a good week, as its shares rose 7.5% to close at HK$13.11...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/the-innocare-pharma-limited-hkg9969-yearly-results-are-out-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/the-innocare-pharma-limited-hkg9969-yearly-results-are-out-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157407752","title":"Stock Track | InnoCare Pharma Soars 5.08% Intraday on Strong Q4 Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1157407752","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157407752?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:09","pubTimestamp":1774577352,"startTime":"0","endTime":"0","summary":"InnoCare Pharma's stock soared 5.08% during intraday trading on Friday, reflecting positive market sentiment following the release of its quarterly financial results.The company reported a sharp...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622486033","title":"InnoCare Pharma (SEHK:9969) Q4 Profit Surge Challenges Bearish Earnings Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2622486033","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622486033?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:15","pubTimestamp":1774534502,"startTime":"0","endTime":"0","summary":"Intro\nInnoCare Pharma (SEHK:9969) just closed FY 2025 with fourth quarter revenue of C¥1.3b and net income of C¥706.9m, a sharp step up from the smaller quarterly figures that characterised most of the year. The company has seen quarterly revenue move from C¥311.7m in Q4 2024 to C¥381.3m in Q1 2025, C¥350.2m in Q2, C¥383.9m in Q3 and finally C¥1.3b in Q4, while basic EPS across the year swung between a gain of C¥0.01 in Q1 and losses of C¥0.0396 and C¥0.0188 in Q2 and Q3. This sets up a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-q4-profit-surge-challenges-bearish","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-sehk9969-q4-profit-surge-challenges-bearish","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127956704","title":"UBS Trims Innocare Pharma Target to HK$19.8, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1127956704","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127956704?lang=en_us&edition=fundamental","pubTime":"2026-03-26 16:18","pubTimestamp":1774513124,"startTime":"0","endTime":"0","summary":"UBS has revised its forecasts for Innocare Pharma (09969), lowering sales projections for 2026 and 2027 while increasing expense estimates. This adjustment reduces the earnings per share forecast for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","688428","BK0239","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622368079","title":"Press Release: InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2622368079","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622368079?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:04","pubTimestamp":1774443840,"startTime":"0","endTime":"0","summary":"BEIJING, March 25, 2026  -- InnoCare Pharma , a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.2025 marked InnoCare's 10th anniversary and a milestone year of transformative growth and strategic execution. The Company achieved its first full year profitability, secured two new drug application  approvals, enhanced market penetration of its core products, accelerated globalization, and made breakthroughs across multiple pipelines. With numerous \"China First\" achievements, InnoCare continues to accelerate its 2.0 development strategy, demonstrating its strong ability to translate scientific innovations into sustainable long-term growth.-- Revenue grew 135.3% year-on-year to RMB 2,375 million1 in 2025, mainly. driven by robust commercial growth and two strategic business development. -- Profit reached RMB 644 million, achieving profitability for the first. time, mainly due to significant com","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","09969","BK4588","CSCO","LU2237443465.HKD","LU0203345920.USD","BK4525","LU1244550577.SGD","LU1599440770.SGD","LU0792757196.USD","LU0320765646.SGD","LU2237443895.HKD","LU2102340556.USD","LU1066051225.USD","LU1032955483.USD","LU1571399168.USD","IE00BSNM7G36.USD","LU1585245621.USD","IE00B42XCP33.USD","SG9999015945.SGD","TLS","LU1235294995.USD","ORR","LU1066051498.USD","BK4579","LU0234572021.USD","LU1674673428.USD","IE00BVYPNW00.USD","CSCL","SG9999001424.SGD","LU1894683348.USD","LU2237443978.SGD","LU2286300806.USD","IE00BGHQF631.EUR","LU0823417653.USD","LU1059921491.USD","BK4533","LU0234570918.USD","LU1929549753.HKD","SG9999015978.USD","LU1894683264.USD","BK4585","BK4020","IE00BVYPNV92.GBP","LU1883839398.USD","LU1221951046.USD","CSCS","SG9999015986.USD","LU2506952170.USD","LU1880398471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622076953","title":"InnoCare Pharma Turns to 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2622076953","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622076953?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:52","pubTimestamp":1774443128,"startTime":"0","endTime":"0","summary":"InnoCare Pharma  recorded an attributable profit of 642.5 million yuan in the year 2025, compared with an attributable loss of 440.6 million yuan a year prior, according to a Wednesday Hong Kong bourse filing.Earnings per share stood at 0.38 yuan for the period, compared with a loss per share of 0.26 yuan in the previous fiscal year.The pharmaceutical company's revenue surged 135% to 2.37 billion yuan from 1.01 billion yuan previously, mainly due to strong drug sales growth and licensing revenue from collaborations with Zenas Biopharma and Prolium.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196547564","title":"InnoCare Updates Nomination Committee Charter to Strengthen Board Oversight and Diversity","url":"https://stock-news.laohu8.com/highlight/detail?id=1196547564","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196547564?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:41","pubTimestamp":1774438871,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited released the latest Terms of Reference for its Nomination Committee, detailing an expanded governance framework designed to enhance board oversight, diversity, and succession...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170960344","title":"InnoCare Pharma Publishes Updated Terms of Reference for Compensation Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1170960344","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170960344?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:40","pubTimestamp":1774438857,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited released a comprehensive update to the Terms of Reference for its Compensation Committee, detailing membership structure, authority and key responsibilities. Key structural...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131693651","title":"InnoCare Proposes Sixth Amended Articles to Introduce Treasury Shares, Hybrid Meetings and E-Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=1131693651","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131693651?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:21","pubTimestamp":1774437672,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced a plan to replace its Fifth Amended and Restated Memorandum and Articles of Association with a Sixth Amended version that incorporates the latest requirements of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142715640","title":"InnoCare Pharma Updates Audit Committee Charter to Strengthen Financial Oversight and Governance","url":"https://stock-news.laohu8.com/highlight/detail?id=1142715640","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142715640?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:20","pubTimestamp":1774437647,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited released an updated Terms of Reference for its Audit Committee, detailing expanded governance structures, membership requirements and oversight responsibilities. Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144782763","title":"InnoCare Announces Company Secretary Transition Effective 25 March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1144782763","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144782763?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:20","pubTimestamp":1774437633,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited (InnoCare) has disclosed a forthcoming change in its senior corporate governance roles. Ms. Lee Angel Pui Shan has tendered her resignation as Company Secretary, Authorised...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114953658","title":"INNOCARE Announces Appointment of Lian Shao'e as Company Secretary and Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1114953658","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114953658?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:12","pubTimestamp":1774437138,"startTime":"0","endTime":"0","summary":"INNOCARE (09969) has announced that Ms. Li Xie Peishan has submitted her resignation from the positions of Company Secretary and, under Rule 3.05 of the Hong Kong Stock Exchange's Listing Rules,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","09969","BK0239","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197972507","title":"Innocare Reports 2025 Financial Results: Achieves Profitability with Net Income of Approximately 644 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1197972507","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197972507?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:08","pubTimestamp":1774436909,"startTime":"0","endTime":"0","summary":"Innocare (09969) announced its 2025 financial results, reporting revenue of approximately 2.375 billion yuan, a year-on-year increase of 135.27%. The company achieved a net profit of around 644...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688428","BK1161","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117163402","title":"InnoCare redistributes RMB 2.78 billion STAR-Market IPO funds; key R&D project ICP-248 receives larger allocation","url":"https://stock-news.laohu8.com/highlight/detail?id=1117163402","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117163402?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:04","pubTimestamp":1774436654,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited (InnoCare) announced a board-approved adjustment in the internal allocation of the RMB 2.78 billion net proceeds raised from its STAR-Market IPO in September 2022. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102493788","title":"InnoCare Posts First-Ever Profit: 2025 Revenue Jumps 135% to RMB 2.37 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1102493788","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102493788?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:03","pubTimestamp":1774436637,"startTime":"0","endTime":"0","summary":"InnoCare Pharma reported full-year 2025 revenue of RMB 2.37 billion, a 135.30% surge from 2024, driven by strong growth in drug sales and new licensing income. • Drug revenue grew 43.40% year-on-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185110573","title":"Innocare Shares Climb Over 5% on Milestone in VAV1 Degrader Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1185110573","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185110573?lang=en_us&edition=fundamental","pubTime":"2026-03-17 11:11","pubTimestamp":1773717063,"startTime":"0","endTime":"0","summary":"Innocare (09969) saw its shares rise more than 5% during the morning session. By the time of writing, the stock was up 3.41%, trading at HK$12.42 with a turnover of HK$54.5545 million. The catalyst...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK4585","09969","BK1574","BK4588","VXUS","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620496361","title":"The Bull Case For InnoCare Pharma (SEHK:9969) Could Change Following First-in-China VAV1 Degrader Trial Start","url":"https://stock-news.laohu8.com/highlight/detail?id=2620496361","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620496361?lang=en_us&edition=fundamental","pubTime":"2026-03-17 01:22","pubTimestamp":1773681741,"startTime":"0","endTime":"0","summary":"InnoCare Pharma recently dosed the first healthy volunteer in a China clinical trial of ICP-538, an oral VAV1-directed molecular glue degrader for autoimmune diseases, marking the first VAV1 degrader to reach trials in China and only the second globally.\nThis move positions InnoCare at the forefront of a new class of targeted immunology drugs, in an area where no VAV1-focused therapies are yet approved worldwide.\nWe’ll now examine how advancing ICP-538, a first-in-China VAV1 degrader, could...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/the-bull-case-for-innocare-pharma-sehk9969-could-change-foll","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/the-bull-case-for-innocare-pharma-sehk9969-could-change-foll","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4587","AIYY","AI","BK4528","BK4551","BK4585","BK4543","BK1161","BK4023","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187703824","title":"InnoCare Pharma (09969) Sets 25 March 2026 Board Meeting to Approve FY2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1187703824","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187703824?lang=en_us&edition=fundamental","pubTime":"2026-03-12 16:45","pubTimestamp":1773305119,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited (Stock code: 09969) announced that its Board of Directors will convene on Wednesday, 25 March 2026. The primary agenda is to consider and approve the consolidated annual...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":0.2516},{"period":"1month","weight":0.3882},{"period":"3month","weight":0.2416},{"period":"6month","weight":-0.1788},{"period":"1year","weight":0.6564},{"period":"ytd","weight":0.2618}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.120269},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.042592},{"month":6,"riseRate":0.833333,"avgChangeRate":0.12939},{"month":7,"riseRate":0.5,"avgChangeRate":0.039258},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"INNOCARE","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOCARE,09969,INNOCARE股票,INNOCARE股票老虎,INNOCARE股票老虎国际,INNOCARE行情,INNOCARE股票行情,INNOCARE股价,INNOCARE股市,INNOCARE股票价格,INNOCARE股票交易,INNOCARE股票购买,INNOCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}